Larsen S S, Madsen M W, Jensen B L, Lykkesfeldt A E
Department of Tumor Endocrinology, Danish Cancer Society, Copenhagen O.
Int J Cancer. 1997 Sep 17;72(6):1129-36. doi: 10.1002/(sici)1097-0215(19970917)72:6<1129::aid-ijc31>3.0.co;2-x.
To elucidate the mechanisms responsible for the development of anti-estrogen resistance, we have cloned and established 3 stable ICI-182,780-resistant sub-lines, MCF-7/182R-1, MCF-7/182R-6 and MCF-7/182R-7 from the estrogen-receptor(ER)-positive and estrogen-responsive human breast-cancer MCF-7 cell line by long-term treatment with 10(-7) M ICI 182,780. The ICI-182,780-resistant MCF-7 sub-lines express ER, but compared with MCF-7 cells the level is significantly lower in all 3 sub-lines. In the MCF-7 cell line we find that ER expression is regulated by estrogen and anti-estrogens at the transcriptional and post-transcriptional level. This is in contrast to the ICI-182,780-resistant sub-lines, in which we find very little hormonal effects on the ER mRNA expression level. The resistant sub-lines also deviate from parent characteristics by the complete lack of expression of progesterone receptor even when grown in the presence of estradiol. All 3 resistant sub-lines have a lower basal expression of cathepsin-D mRNA comparable with the lower ER expression, but, in contrast, they have higher basal expression of the pS2 mRNA than the parent MCF-7 cell line. Although there are different basal expression levels of the pS2 and cathepsin-D genes, the resistant sub-lines behave like the parent MCF-7 cell line with respect to the hormonal regulation of both genes. The estrogen receptors in the resistant sub-lines have also maintained wild-type characteristics with respect to estrogen and anti-estrogen regulation of the estrogen-regulated proteins procathepsin D, alpha1-antitrypsin and a 42-kDa protein. The resistant cells require estrogen for growth in athymic nude mice. Our results clearly demonstrate that the ER in the resistant sub-lines have a normal function for most parameters investigated, supporting our earlier observation that only wild-type ER protein is expressed in these cells. The few observed differences in ER function between the parent MCF-7 cell line and the resistant sub-lines are not likely to be responsible for the ICI-182,780-resistant phenotype.
为阐明抗雌激素耐药性产生的机制,我们通过用10(-7)M ICI 182,780长期处理雌激素受体(ER)阳性且对雌激素有反应的人乳腺癌MCF-7细胞系,克隆并建立了3个稳定的对ICI-182,780耐药的亚系,即MCF-7/182R-1、MCF-7/182R-6和MCF-7/182R-7。对ICI-182,780耐药的MCF-7亚系表达ER,但与MCF-7细胞相比,所有3个亚系中的ER水平均显著降低。在MCF-7细胞系中,我们发现ER表达在转录和转录后水平受雌激素和抗雌激素调节。这与对ICI-182,780耐药的亚系形成对比,在这些亚系中,我们发现激素对ER mRNA表达水平几乎没有影响。即使在雌二醇存在的情况下生长,耐药亚系也因完全缺乏孕激素受体表达而偏离亲本特征。所有3个耐药亚系组织蛋白酶D mRNA的基础表达水平均较低,这与较低的ER表达水平相当,但相比之下,它们pS2 mRNA的基础表达水平高于亲本MCF-7细胞系。尽管pS2和组织蛋白酶D基因的基础表达水平不同,但耐药亚系在这两个基因的激素调节方面表现得与亲本MCF-7细胞系相似。耐药亚系中的雌激素受体在雌激素调节蛋白组织蛋白酶原D、α1-抗胰蛋白酶和一种42 kDa蛋白的雌激素和抗雌激素调节方面也保持了野生型特征。耐药细胞在无胸腺裸鼠中生长需要雌激素。我们的结果清楚地表明,耐药亚系中的ER在大多数研究参数方面具有正常功能,支持了我们早期的观察结果,即这些细胞中仅表达野生型ER蛋白。亲本MCF-7细胞系与耐药亚系之间观察到的少数ER功能差异不太可能是导致ICI-182,780耐药表型的原因。